Defense Advanced Research Projects AgencyTagged Content List

Prevention and Therapy

Biomedical technologies designed to thwart initial infection or injury, or enable faster healing afterward

Showing 50 results for Therapy RSS
January 30, 2018,
Executive Conference Center
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Preventing Emerging Pathogenic Threats (PREEMPT) program. PREEMPT aims to predict and contain viral mutations to prevent cross-species transmission of viral infectious disease from animals and insects to humans.
May 17, 2019,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day meeting to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. The goal of ReVector is to develop an easily delivered treatment — for example, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes.
The Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program supports individual troop readiness and total force health protection by developing technologies to rapidly identify and respond to threats posed by natural and engineered diseases and toxins. A subset of ADEPT technologies specifically support use by personnel with minimal medical training, delivering centralized laboratory capabilities even in the low-resource environments typical of many military operations. The program is part of a portfolio of DARPA-funded research aimed at providing options for preempting or mitigating constantly evolving infectious disease threats.
The Battlefield Medicine program supports military readiness in far-forward deployed settings by overcoming logistical obstacles to manufacturing and delivery of urgently needed pharmaceutical products used to treat emerging threats.
The Biostasis program aims to extend the time for lifesaving medical treatment, often referred to as “the Golden Hour,” following traumatic injury or acute infection, thus increasing survivability for military personnel operating in far-forward conditions with limited access to medical professionals or trauma centers. To do so, Biostasis is developing novel chemical biology approaches that reversibly and controllably slow biological systems without cold-chain to stabilize and protect their functional capacity until medical intervention is possible.